EVO

Evotec SE [EVO] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

EVO Stock Summary

Top EVO Correlated Resources

EVO


Top 10 Correlated ETFs

EVO


Top 10 Correlated Stocks

EVO


In the News

03:10 07 Dec 2022 EVO

Evotec SE (EVOTF) Q3 2022 Earnings Call Transcript

Evotec SE (OTCPK:EVOTF) Q3 2022 Results Conference Call November 9, 2022 8:00 AM ET Company Participants Werner Lanthaler - Chief Executive Officer Enno Spillner - Chief Financial Officer Craig Johnstone - Chief Operating Officer Cord Dohrmann - Chief Scientific Officer Matthias Evers - Chief Business Officer Conference Call Participants Zoe Karamanoli - RBC Capital Markets Christian Ehmann - Warburg Research James Quigley - Morgan Stanley Derik de Bruin - Bank of America Peter Welford - Jefferies Joe Hedden - Rx Securities Steven Mah - Cowen Falko Friedrichs - Deutsche Bank Victoria English - Evernow Publishing Limited Werner Lanthaler Good morning, good afternoon. Welcome from Evotec.

07:15 07 Dec 2022 EVO

Evotec SE to Announce Results for the First Nine Months 2022 on 09 November 2022

HAMBURG, GERMANY / ACCESSWIRE / November 3, 2022 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) will announce its financial results for the first nine months 2022 on Wednesday, 09 November 2022. The Company is going to hold a conference call to discuss the results as well as to provide an update on its performance.

07:29 07 Dec 2022 EVO

Evotec SE's (EVOTF) CEO Dr. Werner Lanthaler on Q2 2022 Results - Earnings Call Transcript

Evotec SE (OTCPK:EVOTF) Q2 2022 Earnings Conference Call August 11, 2022 8:00 AM ET Company Participants Dr. Werner Lanthaler - Chief Executive Officer Enno Spillner - Chief Financial Officer Cord Dohrmann - Chief Scientific Officer Craig Johnstone - Chief Operating Officer Matthias Evers - Chief Business Officer Conference Call Participants Zoe Karamanoli - RBC Capital Markets James Quigley - Morgan Stanley Christian Ehmann - Warburg Research Steven Mah - Cowen Derik de Bruin - Bank of America Falko Friedrichs - Deutsche Bank Joseph Hedden - Rx Securities Operator Good day, ladies and gentlemen. And welcome to the Evotec SE Half Year Report 2022 Conference Call.

05:30 07 Dec 2022 EVO

Evotec SE Reports First Half-year 2022 Results on 11 August 2022

HAMBURG, GERMANY / ACCESSWIRE / August 4, 2022 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its financial results for the first half-year 2022 on Thursday, 11 August 2022. The Company is going to hold a conference call to discuss the results as well as to provide an update on its performance.

12:20 07 Dec 2022 EVO

Evotec (EVO) Inks Drug Discovery Collaboration Deal With J&J

Evotec (EVO) signs a collaboration agreement with Janssen, a wholly owned subsidiary of J&J, for discovering novel drugs in the field of protein homeostasis. Shares down.

08:45 07 Dec 2022 EVO

Evotec SE to Announce Results for the First Quarter 2022 on 11 May 2022

HAMBURG, GERMANY / ACCESSWIRE / May 4, 2022 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) will announce its financial results for the first quarter of 2022 on Wednesday, 11 May 2022. The Company is going to hold a conference call to discuss the results as well as to provide an update on its performance.

08:55 07 Dec 2022 EVO

Evotec SE to Announce Results for Fiscal Year 2021 on 12 April 2022

HAMBURG, GERMANY / ACCESSWIRE / April 5, 2022 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, ISIN: DE0005664809); (NASDAQ:EVO) will announce its financial results for 2021 on Tuesday, 12 April 2022. The Company is going to hold a conference call to discuss the results as well as to provide an update on its performance.

07:10 07 Dec 2022 EVO

Here Are 2 Great Ways to Make an Investment in Online Betting Less Risky

Sometimes a larger playing field is what it takes to score.

EVO Financial details

Company Rating
Buy
Market Cap
3.23B
Income
-179.93M
Revenue
697.83M
Book val./share
3.48
Cash/share
2.35
Dividend
-
Dividend %
-
Employees
4.72K
Optionable
No
Shortable
Yes
Earnings
-
P/E
416
Forward P/E
-
PEG
-1.58
P/S
3.58
P/B
2.03
P/C
3.57
P/FCF
20.66
Quick Ratio
2.98
Current Ratio
3.22
Debt / Equity
0.39
LT Debt / Equity
0.39
-
-
EPS (TTM)
-0.51
EPS next Y
-
EPS next Q
-
EPS this Y
3150%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
50.21%
Revenue last 5Y
19.13%
Revenue Q/Q
0.98%
EPS Q/Q
70.78%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-30.77%
Inst Own
2.97%
Inst Trans
0.1%
ROA
-8%
ROE
-14%
ROC
-
Gross Margin
21%
Oper. Margin
-
Profit Margin
-26%
Payout
-
Shs Outstand
353.9M
Shs Float
285.78M
-
-
-
-
Target Price
-
52W Range
7.83-25.29
52W High
-66.44%
52W Low
+19.86%
RSI
44
Rel Volume
2.23
Avg Volume
61.56K
Volume
137.27K
Perf Week
-0.12%
Perf Month
-14.3%
Perf Quarter
-31.23%
Perf Half Y
-39.73%
-
-
-
-
Beta
1.14815
-
-
Volatility
0.34%, 0.52%
Prev Close
0.84%
Price
8.39
Change
-1.06%

EVO Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
0.891.271.491.631.86
Net income per share
0.080.290.130.020.65
Operating cash flow per share
0.040.530.140.150.37
Free cash flow per share
-0.020.440.03-0.180.01
Cash per share
0.350.511.071.62.58
Book value per share
1.141.441.592.354.14
Tangible book value per share
-0.080.270.351.233.27
Share holders equity per share
1.141.441.592.354.14
Interest debt per share
0.660.41.571.631.57
Market cap
2.37B2.95B3.47B5.14B5.55B
Enterprise value
2.49B2.95B3.65B5.21B5.36B
P/E ratio
97.5135.0391.09822.8725.74
Price to sales ratio
9.187.857.7710.278.98
POCF ratio
218.4518.8782.15115.0445.38
PFCF ratio
-349.9522.97336.34-94.651.68K
P/B Ratio
7.156.957.277.124.03
PTB ratio
7.156.957.277.124.03
EV to sales
9.667.878.1810.418.67
Enterprise value over EBITDA
51.1827.8732.1557.7316.93
EV to operating cash flow
229.818.9186.56116.643.86
EV to free cash flow
-368.1423.01354.39-95.941.63K
Earnings yield
0.010.030.0100.04
Free cash flow yield
00.040-0.010
Debt to equity
0.060.140.930.640.34
Debt to assets
0.50.450.60.510.38
Net debt to EBITDA
2.530.051.640.77-0.59
Current ratio
0.731.272.623.163.39
Interest coverage
29.7329.98.45.734.43
Income quality
0.451.861.117.150.57
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.160.150.150.150.16
Research and developement to revenue
0.070.090.130.130.12
Intangibles to total assets
0.530.450.320.240.13
Capex to operating cash flow
-1.62-0.18-0.76-2.22-0.97
Capex to revenue
-0.07-0.07-0.07-0.2-0.19
Capex to depreciation
-0.85-0.89-0.65-1.77-1.69
Stock based compensation to revenue
0.010.010.010.010.01
Graham number
1.463.042.131.047.77
ROIC
0.090.130.060.040.02
Return on tangible assets
0.080.20.050.010.11
Graham Net
-0.79-0.66-1.26-0.780.44
Working capital
-65.52M53.49M290.58M450.39M776.42M
Tangible asset value
-23.46M81.1M104.12M377.44M1.09B
Net current asset value
-155.27M-97.23M-234.35M-81.21M243.46M
Invested capital
0.570.270.970.680.37
Average receivables
00000
Average payables
34.31M36.84M36.93M42.55M57.57M
Average inventory
11.3M9.62M12.17M13.59M19.69M
Days sales outstanding
0000104.39
Days payables outstanding
54.3743.1536.4641.3956.8
Days of inventory on hand
18.87.8412.5113.2220.18
Receivables turnover
00003.5
Payables turnover
6.718.4610.018.826.43
Inventory turnover
19.4146.5429.1727.6218.09
ROE
0.070.20.080.010.16
Capex per share
-0.06-0.09-0.11-0.32-0.36

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q3

Metric History 2021-09-302021-12-312022-03-312022-06-30 2022-09-30
Revenue per share
0.490.530.470.490.49
Net income per share
0.41-0.09-0.21-0.08-0.13
Operating cash flow per share
0.060.170.180.5-0.01
Free cash flow per share
-0.020.120.060.39-0.23
Cash per share
1.32.432.422.522.35
Book value per share
3.023.93.713.613.48
Tangible book value per share
2.143.082.892.82.62
Share holders equity per share
3.023.93.713.613.48
Interest debt per share
1.531.461.481.381.4
Market cap
6.65B7.13B4.54B3.6B2.64B
Enterprise value
6.81B6.95B4.4B3.38B2.67B
P/E ratio
12.37-56.66-15.51-32.2-13.96
Price to sales ratio
41.6338.1427.620.915.19
POCF ratio
319.58118.2571.4420.33-664.44
PFCF ratio
-975.52171.6219.625.98-33.08
P/B Ratio
6.75.183.472.822.15
PTB ratio
6.75.183.472.822.15
EV to sales
42.6737.1426.7419.6615.35
Enterprise value over EBITDA
47.87-468.79-68.18-163.77-66.2
EV to operating cash flow
327.62115.1669.2119.12-671.53
EV to free cash flow
-1K167.12212.7424.43-33.44
Earnings yield
0.020-0.02-0.01-0.02
Free cash flow yield
00.0100.04-0.03
Debt to equity
0.450.340.360.370.39
Debt to assets
0.440.380.40.440.46
Net debt to EBITDA
1.1712.582.210.35-0.7
Current ratio
2.483.393.133.573.22
Interest coverage
9.154.960.11-1.03-4.43
Income quality
0.15-1.92-0.87-6.340.08
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.150.130.1900
Research and developement to revenue
0.110.10.110.110.11
Intangibles to total assets
0.160.130.130.120.13
Capex to operating cash flow
-1.33-0.31-0.67-0.2219.08
Capex to revenue
-0.17-0.1-0.26-0.22-0.44
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
5.262.84.162.533.23
ROIC
0.010.0100-0.01
Return on tangible assets
0.09-0.02-0.04-0.01-0.02
Graham Net
-1.020.41-0.020-0.14
Working capital
374.53M776.42M721.89M823.91M755.02M
Tangible asset value
705.74M1.09B1.02B989.55M924.37M
Net current asset value
-146.86M243.46M186.35M126.29M61.68M
Invested capital
0.50.370.40.380.4
Average receivables
0163.3M0149.84M168.92M
Average payables
68.81M76.75M77.82M80.89M82.43M
Average inventory
25.76M27.39M27.54M29M29.93M
Days sales outstanding
085.04078.3197.3
Days payables outstanding
43.8248.450.8151.5251.95
Days of inventory on hand
17.417.217.7318.4719.1
Receivables turnover
01.0601.150.92
Payables turnover
2.051.861.771.751.73
Inventory turnover
5.175.235.084.874.71
ROE
0.14-0.02-0.06-0.02-0.04
Capex per share
-0.08-0.05-0.12-0.11-0.21

EVO Frequently Asked Questions

What is Evotec SE stock symbol ?

Evotec SE is a DE stock and trading under the symbol EVO

What is Evotec SE stock quote today ?

Evotec SE stock price is $8.39 today.

Is Evotec SE stock public?

Yes, Evotec SE is a publicly traded company.

Something similar

Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap